Arakawa Y, Saito R, Kanemura Y, Mishima K, et al. Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naive isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas. Neuro Oncol 2025 Nov 8:noaf258. doi: 10.1093.
PMID: 41206766